Verification note: HSA registration status, MOH subsidy criteria, and clinic pricing change frequently. Information here reflects publicly available data as of May 2026. Always verify current status at hsa.gov.sg before making treatment decisions.
The peptide scene in Singapore is smaller than in the US or Australia, but it’s growing, driven by the wellness clinic expansion, the biohacking community, and athletes looking for recovery tools. Here’s how it actually works in 2026.
Warning: Most research peptides discussed below (BPC-157, TB-500, GHK-Cu) are not registered with HSA for human use. This guide is educational. Importing peptides into Singapore without a prescription is illegal and HSA enforcement is active. Talk to a Singapore-registered doctor before using any of them.
What HSA Regulates
Singapore’s Health Sciences Authority is the regulatory body for all medicines. The categories that matter for peptides:
- Registered medicines: Drugs that have gone through HSA approval. Most research peptides are NOT in this category.
- Unregistered medicines for a named patient: HSA’s Special Access Routes let a licensed hospital, clinic or pharmacy bring in an unregistered medicine for one patient, mainly for serious or life-threatening conditions with no registered alternative. HSA does not assess these products, and the doctor is responsible for their use.
- Compounded medicines: HSA lets licensed pharmacies and clinics compound a medicine only when no registered product is commercially available in Singapore, and only on a valid prescription when it contains a prescription-only ingredient.
In practice: BPC-157, TB-500 and most other research peptides have no registered product in Singapore, and HSA has published no guidance naming them as suitable for compounding or special access.
What’s Available in Singapore: HSA Status by Peptide
The peptides Singapore users ask about most, none of which is registered with HSA:
- BPC-157: The most-requested research peptide. Used for soft tissue recovery. Not registered with HSA.
- TB-500 (Thymosin Beta-4): Similar use case to BPC-157. Not registered with HSA.
- GHK-Cu: Skin and connective tissue support. Injectable GHK-Cu is not registered with HSA.
- MOTS-c: Mitochondrial peptide. Not registered with HSA.
- Semax / Selank: Neurological peptides. Very niche, limited access.
Ready to track your protocol?
- Smart reminders so you never miss a dose
- Progress tracking with photos and weight
- Medication level curves for 150+ compounds
Compounding Pharmacies in Singapore: What HSA Allows
HSA allows licensed pharmacies and clinics to compound a medicine only when no registered product is commercially available in Singapore. The work must happen on their own licensed premises, by or under a pharmacist or doctor, and a medicine with a prescription-only ingredient needs a valid prescription. HSA has published no guidance naming BPC-157, TB-500 or other research peptides.
What to Monitor and Track
Peptide protocols are dose-, frequency-, and reconstitution-sensitive. The variables worth tracking:
- Reconstitution date and concentration (peptides have limited refrigerated stability)
- Dose per injection (in mg or mcg)
- Injection site rotation
- Subjective response (recovery time, pain levels, soft tissue healing)
For multi-peptide protocols (a common pattern: BPC-157 + TB-500 stacked for injury recovery), tracking each compound separately matters. This is exactly the use case Regimen is built for.
Common Mistakes Singaporean Peptide Users Make
- Importing from overseas suppliers: Medicines brought in without a valid prescription, or beyond HSA’s personal import limits, can be confiscated.
- Storing reconstituted vials too long: Most peptides last 28 days refrigerated after reconstitution. After that, potency drops and contamination risk rises.
- Skipping injection site rotation: Same site repeatedly leads to localized scar tissue. Rotate.
- Not tracking reconstitution dates: When did you mix this vial? If you don’t know, you don’t know if it’s still good.
Tracking Your Protocol with Regimen
Track your peptide protocol with Regimen.
For TRT in Singapore, see the TRT Singapore Guide 2026. For GLP-1 medications, see the Ozempic and Mounjaro Singapore Guide 2026.
Frequently Asked Questions
Are peptides legal in Singapore?
BPC-157 and TB-500 are not registered with HSA, so there is no approved product in Singapore. HSA lets licensed pharmacies and clinics compound a medicine only when no registered product is available and only on a doctor’s prescription, and it has published no guidance naming these peptides. Bringing medicines into Singapore for personal use requires a valid prescription.
How do I get BPC-157 in Singapore?
There is no HSA-registered BPC-157 product in Singapore. A doctor can only use an unregistered medicine through HSA’s compounding rules or its Special Access Routes, which are meant for serious conditions with no registered alternative. Your doctor can tell you whether either applies to you.
How much do peptides cost in Singapore?
HSA has not registered BPC-157 or TB-500, so there is no approved product or official price in Singapore.
Can I import peptides into Singapore for personal use?
Only with a valid prescription. HSA’s personal import rules allow up to 3 months’ supply, with a copy of the prescription or doctor’s letter and the original labelled packaging, and medicines brought in outside these rules can be confiscated. BPC-157, TB-500 and GHK-Cu injections are not registered with HSA.
How do I track multiple peptides at once?
Log each peptide separately with its reconstitution date, concentration, dose per injection, and injection site. For stacks like BPC-157 + TB-500, tracking each compound’s protocol on its own timeline matters. Regimen handles multi-compound tracking.
Track your peptide protocol with Regimen. Log reconstitution dates, doses, and injection sites. Free for one compound.
Regimen is a tracking tool, not a medical service. We do not provide medical advice. Always consult your healthcare professional before starting, changing, or stopping any medication protocol.
